Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
0.94
0.04 (4.76%)
At close: Aug 15, 2025, 2:25 PM
4.76% (1D)
| Bid | 0.93 |
| Market Cap | 886.55K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.4M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -1.47 |
| Forward PE | -2.62 |
| Analyst | Strong Buy |
| Ask | 0.94 |
| Volume | 59,294 |
| Avg. Volume (20D) | 155,366 |
| Open | 0.91 |
| Previous Close | 0.90 |
| Day's Range | 0.91 - 0.95 |
| 52-Week Range | 0.87 - 2.55 |
| Beta | 0.57 |
About CMMB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMMB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMMB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 day ago
-6.34%
CMMB stock has given up its prior gain. Chemomab T...
Unlock content with
Pro Subscription
1 day ago
-6.34%
Chemomab Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
